Examining how older cancer patients tolerate treatment

Understanding Treatment Tolerability in Older Patients with Cancer

['FUNDING_U01'] · UNIVERSITY OF ROCHESTER · NIH-10479177

This study is looking at how older adults starting new cancer treatments handle side effects and their overall well-being, especially considering any other health issues they might have, to better understand their experiences and improve their care.

Quick facts

Phase['FUNDING_U01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF ROCHESTER (nih funded)
Locations1 site (ROCHESTER, UNITED STATES)
Trial IDNIH-10479177 on ClinicalTrials.gov

What this research studies

This research investigates the tolerability of cancer treatments in older patients, focusing on how age-related conditions like disability and comorbidities affect their experience. By using patient-reported outcomes, the study aims to identify factors that contribute to treatment-related side effects and overall quality of life. The research involves a multi-site approach, enrolling older adults who are beginning new cancer treatments, to gather comprehensive data on their experiences and health outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults aged 70 and above who are starting a new treatment regimen for advanced cancer.

Not a fit: Patients who are younger than 70 or those without advanced cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies that enhance the tolerability of cancer therapies for older patients.

How similar studies have performed: Previous research has indicated that understanding patient-reported outcomes can significantly improve treatment tolerability, suggesting a promising avenue for this study.

Where this research is happening

ROCHESTER, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.